Literature DB >> 3403215

One year follow-up of patients clinically preselected for excessive risk of stroke.

C Fieschi1, M Rasura, G L Lenzi, L Allori, P Fiorani, G Maira, V Faraglia, A Carolei, F Giubilei, M Servi.   

Abstract

From a consecutive series of 812 patients at risk of stroke we selected 100 who seemed to be at high risk (excessive stroke risk--ESR) on the following clinical criteria: either multiple reversible ischemic attacks in one carotid territory or multiple (or bilateral) severe stenotic carotid lesions. The patients of the first subgroup received medical therapy and those of the second were referred for surgery. The 100 patients were followed up for 12 months, during which 29 patients had cerebral ischemic events: 17 having stroke and 12 TIA. This study suggests that it is possible to identify beforehand subgroups of ESR patients, thereby facilitating the selection of patients for brain protection and avoiding huge trials of unselected cerebrovascular patients.

Entities:  

Mesh:

Year:  1988        PMID: 3403215     DOI: 10.1007/bf02334045

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  9 in total

1.  Italian multicenter study on reversible cerebral ischemic attacks: VI--Prognostic factors and follow-up results.

Authors:  L Candelise; M Vigotti; C Fieschi; G L Brambilla; G Bono; P Conforti; L De Zanche; D Inzitari; F Mariani; M Prencipe
Journal:  Stroke       Date:  1986 Sep-Oct       Impact factor: 7.914

2.  Occlusive cerebrovascular disease.

Authors:  W K Hass
Journal:  Med Clin North Am       Date:  1972-11       Impact factor: 5.456

3.  United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. UK-TIA Study Group.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-30

4.  Italian multicenter study on reversible cerebral ischemic attacks: population characteristics and methodology.

Authors:  C Fieschi; F Mariani; G L Brambilla; M Prencipe; F Tomasello; C Argentino; G Bono; L Candelise; L De Zanche; D Inzitari
Journal:  Stroke       Date:  1983 May-Jun       Impact factor: 7.914

Review 5.  Protracted transient ischemic attacks.

Authors:  C Loeb
Journal:  Eur Neurol       Date:  1980       Impact factor: 1.710

6.  ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)].

Authors:  M G Bousser; E Eschwege; M Haguenau; J M Lefauconnier; D Touboul; P J Touboul
Journal:  Rev Neurol (Paris)       Date:  1981       Impact factor: 2.607

7.  Transient ischemic attacks due to atherosclerosis. A prospective study of 160 patients.

Authors:  J F Toole; R Janeway; K Choi; R Cordell; C Davis; F Johnston; H S Miller
Journal:  Arch Neurol       Date:  1975-01

8.  A randomized trial of aspirin and sulfinpyrazone in threatened stroke.

Authors: 
Journal:  N Engl J Med       Date:  1978-07-13       Impact factor: 91.245

9.  Transient ischemic attacks: a prospective study of 225 patients.

Authors:  J F Toole; C P Yuson; R Janeway; F Johnston; C Davis; A R Cordell; G Howard
Journal:  Neurology       Date:  1978-08       Impact factor: 9.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.